These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 9033275

  • 21. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y, Inaba Y, Matsuda K, Itoh M, Kaneyama T, Nakazawa Y, Koh CS, Ichikawa M.
    J Neurol Sci; 2014 May 15; 340(1-2):117-22. PubMed ID: 24655735
    [Abstract] [Full Text] [Related]

  • 22. Characterization of CD8-positive macrophages infiltrating the central nervous system of rats with chronic autoimmune encephalomyelitis.
    Hiraki K, Park IK, Kohyama K, Matsumoto Y.
    J Neurosci Res; 2009 Apr 15; 87(5):1175-84. PubMed ID: 18951531
    [Abstract] [Full Text] [Related]

  • 23. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
    Krakowski ML, Owens T.
    Eur J Immunol; 1997 Nov 15; 27(11):2840-7. PubMed ID: 9394808
    [Abstract] [Full Text] [Related]

  • 24. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis.
    Das Sarma J, Ciric B, Marek R, Sadhukhan S, Caruso ML, Shafagh J, Fitzgerald DC, Shindler KS, Rostami A.
    J Neuroinflammation; 2009 Apr 28; 6():14. PubMed ID: 19400960
    [Abstract] [Full Text] [Related]

  • 25. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
    Hamilton NH, Banyer JL, Hapel AJ, Mahalingam S, Ramsay AJ, Ramshaw IA, Thomson SA.
    Scand J Immunol; 2002 Feb 28; 55(2):171-7. PubMed ID: 11896933
    [Abstract] [Full Text] [Related]

  • 26. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.
    Magliozzi R, Columba-Cabezas S, Serafini B, Aloisi F.
    J Neuroimmunol; 2004 Mar 28; 148(1-2):11-23. PubMed ID: 14975582
    [Abstract] [Full Text] [Related]

  • 27. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.
    Glabinski AR, Bielecki B, Kawczak JA, Tuohy VK, Selmaj K, Ransohoff RM.
    Autoimmunity; 2004 Mar 28; 37(6-7):465-71. PubMed ID: 15621573
    [Abstract] [Full Text] [Related]

  • 28. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo.
    Issazadeh S, Navikas V, Schaub M, Sayegh M, Khoury S.
    J Immunol; 1998 Aug 01; 161(3):1104-12. PubMed ID: 9686568
    [Abstract] [Full Text] [Related]

  • 29. N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
    Bolton C, Wood EG, Ayoub SS.
    Fundam Clin Pharmacol; 2013 Oct 01; 27(5):535-43. PubMed ID: 22742874
    [Abstract] [Full Text] [Related]

  • 30. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines.
    Renno T, Krakowski M, Piccirillo C, Lin JY, Owens T.
    J Immunol; 1995 Jan 15; 154(2):944-53. PubMed ID: 7814894
    [Abstract] [Full Text] [Related]

  • 31. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
    de Mestre AM, Staykova MA, Hornby JR, Willenborg DO, Hulett MD.
    J Leukoc Biol; 2007 Nov 15; 82(5):1289-300. PubMed ID: 17656651
    [Abstract] [Full Text] [Related]

  • 32. Suppression of established experimental autoimmune encephalomyelitis and formation of meningeal lymphoid follicles by lymphotoxin beta receptor-Ig fusion protein.
    Columba-Cabezas S, Griguoli M, Rosicarelli B, Magliozzi R, Ria F, Serafini B, Aloisi F.
    J Neuroimmunol; 2006 Oct 15; 179(1-2):76-86. PubMed ID: 16870269
    [Abstract] [Full Text] [Related]

  • 33. IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
    Cheng W, Zhao Q, Xi Y, Li C, Xu Y, Wang L, Niu X, Wang Z, Chen G.
    Mol Immunol; 2015 Mar 15; 64(1):152-62. PubMed ID: 25433436
    [Abstract] [Full Text] [Related]

  • 34. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S, Berg AL, Lassmann H, Wallström E, Nilsson M, Olsson T, Ericsson-Dahlstrand A, Sunnemark D.
    J Neuroinflammation; 2007 May 07; 4():14. PubMed ID: 17484785
    [Abstract] [Full Text] [Related]

  • 35. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
    Whitham RH, Bourdette DN, Hashim GA, Herndon RM, Ilg RC, Vandenbark AA, Offner H.
    J Immunol; 1991 Jan 01; 146(1):101-7. PubMed ID: 1701788
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL, Wolak K, Fournier S, David S.
    Glia; 2010 Mar 01; 58(4):434-45. PubMed ID: 19780195
    [Abstract] [Full Text] [Related]

  • 38. CCL5-glutamate interaction in central nervous system: Early and acute presynaptic defects in EAE mice.
    Di Prisco S, Merega E, Milanese M, Summa M, Casazza S, Raffaghello L, Pistoia V, Uccelli A, Pittaluga A.
    Neuropharmacology; 2013 Dec 01; 75():337-46. PubMed ID: 23958452
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.